Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas

Recruiting now · Not applicable

Conditions studied: Soft Tissue Sarcoma Adult

In brief

"Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcoma" is a prospective study with additional translational research using preoperative and postoperative tissue, blood sampling and advanced imaging.

Key facts

Study ID

NCT06385288

Run by

University Hospital Tuebingen

People needed

30

Starts

2021-07-21

Expected to finish

2031-07-21

Last updated by the study team

2024-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Planned histological confirmation for especially high-risk soft tissue sarcoma via open Sampling
• Indication for neoadjuvant multimodal therapy (radiation and locoregional Hyperthermia, optionally with simultaneous chemotherapy)
• Planned resection of a department of the CWS
• Age > 18 years
• Ability to consent
• Additionally for imaging study: Treatment on the combined MR hyperthermia device

You may not qualify if…

• Age < 18 years
• Poor understanding (language etc.)
• Lack of reconnaissance ability

Where it is running

• University Hospital Tuebingen — Tübingen, Baden-Wurttemberg, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.